Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.04 - $0.13 $308 - $1,001
-7,700 Reduced 2.49%
301,517 $21,000
Q3 2023

Nov 14, 2023

SELL
$0.12 - $0.5 $12,896 - $53,736
-107,473 Reduced 25.79%
309,217 $40,000
Q2 2023

Aug 14, 2023

SELL
$0.43 - $0.65 $242,636 - $366,775
-564,270 Reduced 57.52%
416,690 $212,000
Q1 2023

May 15, 2023

SELL
$0.46 - $0.81 $301,696 - $531,249
-655,863 Reduced 40.07%
980,960 $618,000
Q4 2022

Feb 14, 2023

BUY
$0.5 - $261.0 $604,957 - $316 Million
1,209,914 Added 283.41%
1,636,823 $1.06 Million
Q3 2022

Nov 14, 2022

SELL
$1.04 - $322.5 $35,207 - $10.9 Million
-33,853 Reduced 7.35%
426,909 $734,000
Q2 2022

Aug 15, 2022

SELL
$0.41 - $1.24 $541,960 - $1.64 Million
-1,321,856 Reduced 74.15%
460,762 $571,000
Q1 2022

May 16, 2022

SELL
$0.62 - $1.17 $525,551 - $991,766
-847,664 Reduced 32.23%
1,782,618 $1.16 Million
Q4 2021

Feb 14, 2022

BUY
$1.09 - $1.89 $2.37 Million - $4.11 Million
2,174,715 Added 477.36%
2,630,282 $2.87 Million
Q3 2021

Nov 15, 2021

SELL
$1.44 - $2.73 $531,745 - $1.01 Million
-369,268 Reduced 44.77%
455,567 $829,000
Q2 2021

Aug 16, 2021

SELL
$2.63 - $3.67 $383,046 - $534,517
-145,645 Reduced 15.01%
824,835 $2.18 Million
Q1 2021

May 17, 2021

BUY
$2.82 - $5.6 $323,281 - $641,978
114,639 Added 13.39%
970,480 $3.49 Million
Q4 2020

Feb 16, 2021

BUY
$2.09 - $3.09 $184,530 - $272,822
88,292 Added 11.5%
855,841 $2.16 Million
Q3 2020

Nov 16, 2020

BUY
$2.39 - $3.43 $1.79 Million - $2.57 Million
750,688 Added 4452.22%
767,549 $1.93 Million
Q2 2020

Aug 14, 2020

SELL
$2.2 - $3.71 $946,858 - $1.6 Million
-430,390 Reduced 96.23%
16,861 $55,000
Q1 2020

May 15, 2020

BUY
$1.9 - $4.98 $607,473 - $1.59 Million
319,723 Added 250.71%
447,251 $1.1 Million
Q4 2019

Feb 14, 2020

BUY
$3.95 - $5.35 $85,999 - $116,480
21,772 Added 20.59%
127,528 $602,000
Q3 2019

Nov 14, 2019

BUY
$4.13 - $6.94 $436,772 - $733,946
105,756 New
105,756 $453,000
Q1 2019

May 15, 2019

SELL
$2.0 - $4.4 $226,924 - $499,232
-113,462 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.61 - $3.62 $182,673 - $410,732
113,462 New
113,462 $212,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $458M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.